Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor.
3-Phenyloxetane 衍生物作為胰高血糖素樣肽-1 受體的激動劑的設計與評估。
J Med Chem 2024-08-14
Design, synthesis, and biological evaluation of a potential long-acting glucagon-like peptide-1 (GLP-1) analog.
設計、合成及生物評估一種潛在的長效葡萄糖樣肽-1(GLP-1)類似物。
Bioorg Med Chem 2023-05-09
Engineering a potent and long-acting GLP-1/Y<sub>2</sub> receptor dual agonist as a multi-agonist therapy for diabetes and obesity.
為糖尿病和肥胖症工程一種強效且長效的 GLP-1/Y<sub>2</sub> 受體雙激動劑,作為多激動劑治療的一部分。
Peptides 2023-10-11
6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor.
6-Azaspiro[2.5]辛烷作為人類胰高血糖素樣肽-1受體的小分子激動劑。
Bioorg Med Chem Lett 2023-09-25
A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency.
利用高效小分子胰高血糖素樣肽-1受體激動劑的新方法。
Bioorg Med Chem 2024-05-25
Pharmacodynamic and pharmacokinetic profiles of a novel GLP-1 receptor biased agonist-SAL0112.
一種新型GLP-1受體偏向性激動劑SAL0112的藥效動力學和藥代動力學特性。
Biomed Pharmacother 2024-06-26